Edition:
United States

People: Mesoblast Ltd (MSB.AX)

MSB.AX on Australia Stock Exchange

1.34AUD
22 Sep 2017
Change (% chg)

$0.01 (+0.75%)
Prev Close
$1.33
Open
$1.35
Day's High
$1.36
Day's Low
$1.33
Volume
391,033
Avg. Vol
850,209
52-wk High
$3.41
52-wk Low
$1.06

Rose, Eric 

Dr. Eric A. Rose, M.D., is an Non-Executive Independent Director of Mesoblast Ltd. He is currently Chairman and Chief Executive Officer of SIGA Technologies and Executive Vice President, Life Sciences at MacAndrews & Forbes, Inc., the holding company of Ronald O. Perelman. From 2008 through 2012, Dr Rose served as the Edmond A. Guggenheim Professor and Chairman of the Department of Health Evidence and Policy at the Mount Sinai School of Medicine. From 1994 through 2007, he served as Chairman of the Department of Surgery and Surgeon-in-Chief of the Columbia Presbyterian Center of New York Presbyterian Hospital. From 1982 through 1992, Dr Rose led the Columbia Presbyterian heart transplantation program in the United States. He currently sits on the Board of Directors of ABIOMED.

Basic Compensation

Total Annual Compensation, AUD 250,531
Restricted Stock Awards, AUD --
Long-Term Incentive Plans, AUD --
All Other, AUD 42,737
Fiscal Year Total, AUD 293,268

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --